ALXO NASDAQ
ALX Oncology Holdings Inc.
1W: -6.9%
1M: -41.4%
3M: -44.3%
YTD: +6.1%
1Y: -32.6%
3Y: -74.4%
5Y: -98.4%
$1.22
-0.08 (-6.15%)
Weekly Expected Move ±9.0%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-10-31
Earliest Filing
2022-10-31
Latest Filing
customer: 3
Counterparties (Filed by ALXO)
3 relationshipsCompanies named in ALXO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| ALX Oncology Inc. | ALXO | customer | Primary borrower in the loan agreement | 2022-10-31 | View |
| Alexo Therapeutics International | — | customer | Borrower in the loan agreement | 2022-10-31 | View |
| Sirpant Therapeutics | — | customer | Borrower in the loan agreement | 2022-10-31 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-06-30 | Officer/Director Change; Regulation FD; Other Events; Exhibits | View | |
| 2026-06-26 | Material Agreement; Termination of Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-06-11 | Shareholder Vote | View | |
| 2026-05-08 | Earnings Release; Exhibits | View | |
| 2026-04-13 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-30 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-01-30 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-21 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-12 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-06-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Results of Operations and Financial Condition | View | |
| 2025-04-25 | Notice of Delisting or Transfer | View | |
| 2025-03-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-05 | Costs Associated with Exit or Disposal Activities; Departure/Election of Directors; Appointment of O | View | |
| 2025-01-22 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Other Events; Fi | View | |
| 2025-01-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR